Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
about
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients.Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancerImmunological battlefield in gastric cancer and role of immunotherapiesClinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis.PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer.Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.Practical Immuno-PET Radiotracer Design Considerations for Human Immune Checkpoint Imaging.Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunologyPrognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis.Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.Predictive relevance of PD-L1 expression with pre-existing TILs in gastric cancer.Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection.Current status of immunotherapy and immune biomarkers in gastro-esophageal cancers.Analysis of PD1, PDL1, PDL2 expression and T cells infiltration in 1014 gastric cancer patients.EBV⁺ and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8⁺ Intratumoral Lymphocytes.Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status.Clinicopathological and prognostic significance of PD-L1 expression in sarcoma: A systematic review and meta-analysis.Advances in immuno-oncology biomarkers for gastroesophageal cancer: Programmed death ligand 1, microsatellite instability, and beyond.Proposed Molecular and miRNA Classification of Gastric Cancer.
P2860
Q27853364-E6F6776B-6805-4187-85DC-A36675865E3DQ28066532-0EB17702-DF08-4300-9C9B-4B8CA0A17756Q28071836-05E2CC93-7981-4507-A7E6-3F45A9914461Q33688662-963A064E-519D-41EE-A62F-DA66E72F5AC0Q36205148-23537F1C-3484-43CA-8023-02C3F05BBE90Q38369260-AD59EC6A-F069-4F75-A2FB-727E9DFAFA5BQ38630412-83D7E021-3E7D-4A77-9DED-BC5319CCC8A4Q38642012-4181AB7D-B765-45B5-9CA5-E4A735B9D86EQ38695286-720C407E-13DA-4867-A636-BE511A2B2FF0Q38726053-93E12F79-D10A-424B-B6F8-47F0964B3B91Q40071292-A094CAAD-20A5-481A-A908-FCE0A85A27AEQ41110505-F231E845-91A9-4C70-A86E-CE0D12CDC556Q41169821-537DB917-7E71-458E-8577-9A43B51E220FQ41709065-84272A90-638D-4E90-9A12-A47A76E62FB2Q45325629-03479176-76B6-4A98-A939-DDEA3FB480C0Q47137632-CB1DDDC2-FB39-4730-9124-0898FB6CEC94Q47143363-018863CD-F5A0-42CD-8892-595656EEDB66Q52643527-C386D2E4-A66B-4D45-A019-210D75E61987Q52733772-1605E380-D84A-4CAD-BCF9-9B4C7F25A622Q55082025-66FF317A-BF68-467F-878D-7B47E17BD785Q55307728-6B1B22F7-F9F3-4451-AFB8-3AFC8ABB938AQ55432051-1A0B3C35-4B3D-43B9-903B-D2029E51674DQ55506755-B0CADC50-01AA-4FEF-8E43-83B793F7B863Q55603677-DED00FDB-BB35-4570-9B03-FDEEEB6A8669
P2860
Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Programmed cell death ligand 1 ...... ith clinicopathologic factors.
@ast
Programmed cell death ligand 1 ...... ith clinicopathologic factors.
@en
type
label
Programmed cell death ligand 1 ...... ith clinicopathologic factors.
@ast
Programmed cell death ligand 1 ...... ith clinicopathologic factors.
@en
prefLabel
Programmed cell death ligand 1 ...... ith clinicopathologic factors.
@ast
Programmed cell death ligand 1 ...... ith clinicopathologic factors.
@en
P2093
P2860
P1476
Programmed cell death ligand 1 ...... ith clinicopathologic factors.
@en
P2093
Dajun Yang
Miaozhen Qiu
Shumei Yan
Xueping Wang
P2860
P304
11084-11091
P577
2015-09-01T00:00:00Z